Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) Given “Neutral” Rating by Zacks Investment Research Analysts
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) Given “Neutral” Rating by Zacks Investment Research Analysts
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) Given “Neutral” Rating by Zacks Investment Research Analysts
Submitted by
admin
on January 2, 2011 - 12:20pm
Source:
American Banking News
News Tags:
Questcor Pharmaceuticals
investors
Headline:
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) Given “Neutral” Rating by Zacks Investment Research Analysts
Do Not Allow Advertisers to Use My Personal information
